A Randomized Study Evaluating GLIADEL Compared to Stereotactic Radiosurgery in Patients with Metastatic Brain Disease
Categories (click each to see list of all clinical trials associated with that category): Brain/Neuro (ONC), Breast (ONC), GI (ONC), Head & Neck (ONC), Thoracic (ONC)
Current Status: Open
Phase: II (Cancer Control)
Principal Investigator: Aizenberg-Ansari, Michele
Contact Information:
Susan Blumel, RN
402-559-9183
sblumel@unmc.edu
Eligibility: https://clinicaltrials.gov/study/NCT04222062?term=NCT04222062&rank=1
Summary
The primary outcome is to evaluate the efficacy of GLIADEL local chemotherapy compared to Stereotactic Radiosurgery (SRS) in preventing local recurrence after resection of a metastatic brain tumor (local recurrence at surgical site).